| Year |
Citation |
Score |
| 2016 |
Blumberg BJ, Flynn SP, Barriere SJ, Mouchati PR, Scott RC, Holmes GL, Barry JM. Efficacy of nonselective optogenetic control of the medial septum over hippocampal oscillations: the influence of speed and implications for cognitive enhancement. Physiological Reports. 4. PMID 27923975 DOI: 10.14814/Phy2.13048 |
0.4 |
|
| 2016 |
Walls AB, Flynn SP, West PJ, Müller MS, Bak LK, Bulaj G, Schousboe A, White HS. The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission. Epilepsy Research. 121: 55-63. PMID 26894875 DOI: 10.1016/J.Eplepsyres.2016.01.006 |
0.546 |
|
| 2015 |
Flynn SP, Barriere S, Scott RC, Lenck-Santini PP, Holmes GL. Correction: Status Epilepticus Induced Spontaneous Dentate Gyrus Spikes: In Vivo Current Source Density Analysis. Plos One. 10: e0136125. PMID 26275312 DOI: 10.1371/Journal.Pone.0136125 |
0.451 |
|
| 2015 |
Flynn SP, Barrier S, Scott RC, Lenck-Santini PP, Holmes GL. Status Epilepticus Induced Spontaneous Dentate Gyrus Spikes: In Vivo Current Source Density Analysis. Plos One. 10: e0132630. PMID 26148195 DOI: 10.1371/journal.pone.0132630 |
0.451 |
|
| 2015 |
Holmes GL, Tian C, Hernan AE, Flynn S, Camp D, Barry J. Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide. Neurobiology of Disease. 77: 204-19. PMID 25766676 DOI: 10.1016/J.Nbd.2015.02.015 |
0.586 |
|
| 2015 |
Flynn SP, White HS. Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055. Neuropeptides. 50: 35-42. PMID 25690510 DOI: 10.1016/J.Npep.2015.01.001 |
0.385 |
|
| 2011 |
Robertson CR, Flynn SP, White HS, Bulaj G. Anticonvulsant neuropeptides as drug leads for neurological diseases. Natural Product Reports. 28: 741-62. PMID 21340067 DOI: 10.1039/C0Np00048E |
0.514 |
|
| 2009 |
White HS, Scholl EA, Klein BD, Flynn SP, Pruess TH, Green BR, Zhang L, Bulaj G. Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 372-80. PMID 19332332 DOI: 10.1016/J.Nurt.2009.01.001 |
0.643 |
|
| 2008 |
Bulaj G, Green BR, Lee HK, Robertson CR, White K, Zhang L, Sochanska M, Flynn SP, Scholl EA, Pruess TH, Smith MD, White HS. Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. Journal of Medicinal Chemistry. 51: 8038-47. PMID 19053761 DOI: 10.1021/Jm801088X |
0.557 |
|
| Show low-probability matches. |